Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00382122 · ClinicalTrials.gov registry record

Prevalence of Ocular Surface Disease in Glaucoma Patients

A clinical trial, sponsored by Alcon Research.

Completed
Registry status
101
Enrollment target

NCT00382122 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00382122 has completed, sponsored by Alcon Research.

COMPLETED
Registry status
101 participants
Enrollment target

Study Summary

Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular surface.

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2006-09
Est. Completion 2007-02

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT00382122

The ClinicalTrials.gov registry entry for NCT00382122 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00382122 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00382122 about?

NCT00382122 is a clinical study titled "Prevalence of Ocular Surface Disease in Glaucoma Patients". Demographic information and a brief medical and concomitant medicine history will be obtained from the glaucoma patient's records. Qualified patients will be asked to complete a questionnaire about their symptoms. Patients will then be scheduled to undergo three standard clinical tests of the ocular...

What is the current status of trial NCT00382122?

This trial is currently completed. The enrollment target is 101 participants. The study started on 2006-09. Estimated completion is 2007-02.

Who is sponsoring clinical trial NCT00382122?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.